Graft viability post thaw
Thaw in warm saline without decanting for
Cell viability post-thaw is at least
of initial viable and active cell count
Cells protected by proprietary cryoprotectant
ALLOCYTE® Plus Advanced
Viable Bone Matrix Proprietary
2.5% DMSO solution
Cytotoxicity assay showing higher number of viable cells in media containing up to 10% cryoprotectant (left) compared to media containing 2.5% DMSO (right), after 48 hours incubation period.
- 1. Data on file.
- 2. Data on file
Keep Up With the Latest Developments
in Surgical and Wound Care Technology
Sign Up for the Sanara MedTech Mailing List
Most Recent Press Releases
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound HealingDecember 1, 2023